The Clorox Company

NYSE:CLX

Household & Personal Products

Consumer Defensive
$108.39 -2.60%

-$2.54 today

Market cap
$13.13B
Beta
0.55
P/E (TTM)
15.2
EPS (TTM)
$6.23
Dividend yield
5.22%
52W Low $84.70High $132.03

Volume 2.16M

Average 2.84M

CLX Revenue

Total income from selling goods and services before any costs are deducted; the top line of the income statement.

The Clorox CompanyNYSE: CLX

Revenue · Q1 FY2027 · quarter ended Sep 2026

Revenue growth accelerates

Q1 FY2027 revenue of $1.91B rose 33.3% year over year, ahead of the +6.3% change in trailing-twelve-month revenue. Sequentially, it fell 2.2% from the prior quarter. Over 3 fiscal years it compounded at -3.1% a year.

Context

  • Revenue increased in 1 of the last 3 fiscal years.
  • FY2026 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether revenue reaches the consensus estimate from 12 analysts of $7.64B (+13.7%) for the fiscal year ending Jun 2027, a step up from the -5.4% reported in FY2026.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterSep 2026
$1.91B-2.2% QoQ
Last fiscal yearJun 2026
$6.72B-5.4% YoY
LTMSep 2026
$7.2B+6.3% YoY
Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+33.3%+11.9%-21.4 pp
1 year-5.4%+13.7%+19.1 pp
3-year CAGR-3.1%+6.0%+9.1 pp
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Revenue history

USD · from the income statement

Latest · FY2026
6.72B USD
Year-over-year change
-5.4%
4-year CAGR
-1.4%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Revenue vs competitors

How CLX compares with its peers on the latest reported figures

  • Peers report in different currencies, so revenue is compared through growth and rates rather than absolute size.
  • Its year-over-year change of +6.3% is the highest of 11, against a peer median of +1.3%.
  • Over three fiscal years its annual growth of -3.1% compares with a peer median of -0.2%.
CLX Competitors
Revenue for CLX and competitors
Company Period LTM YoY 3-year CAGR
PGThe Procter & Gamble CompanyLTM Sep 2026$87.92B USD+3.5%+2.0%
ULUnilever PLCFY2025€50.5B EUR-16.9%-5.6%
CLColgate-Palmolive CompanyLTM Sep 2026$21.28B USD+5.9%+4.3%
KMBKimberly-Clark CorporationLTM Jun 2026$16.57B USD-8.4%-5.1%
KVUEKenvue Inc.LTM Sep 2026$15.53B USD+3.5%+0.4%
CLXThe Clorox CompanyLTM Sep 2026$7.2B USD+6.3%-3.1%
CHDChurch & Dwight Co., Inc.LTM Sep 2026$6.25B USD+1.7%+4.9%
REYNReynolds Consumer Products Inc.LTM Jun 2026$3.79B USD+2.7%-0.8%
SPBSpectrum Brands Holdings, Inc.LTM Jun 2026$2.87B USD+0.8%-3.6%
EPCEdgewell Personal Care CompanyLTM Mar 2026$2.11B USD-5.3%+0.8%
HELEHelen of Troy LimitedLTM Feb 2026$1.79B USD-6.4%-4.8%
Peer median (excluding CLX) —+1.3%-0.2%

Competitors are the stored peer set for CLX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
FY2026
Jun 2026
Revenue7.11B7.39B7.09B7.1B6.72B
Cost of Revenue4.56B4.48B4.05B3.89B3.88B
Gross Profit2.55B2.91B3.05B3.21B2.84B
Gross Margin35.8%39.4%43.0%45.2%42.3%
Research & Development132M138M126M121M116M
Selling, General & Admin1.66B1.92B2.17B1.89B1.07B
Operating Expenses1.83B2.09B2.33B2.04B1.18B
Depreciation & Amortization224M236M235M219M247M
EBITDA937M564M723M1.39B1.17B
EBITDA Margin13.2%7.6%10.2%19.5%17.4%
Operating Income719M823M723M1.18B1.66B
Operating Margin10.1%11.1%10.2%16.6%24.7%
Interest Income5M16M23M9M8M
Interest Expense106M90M90M88M130M
Other Income / Expenses(112M)(585M)(325M)(99M)(871M)
Income Before Tax607M238M398M1.08B791M
Pre-Tax Margin8.5%3.2%5.6%15.2%11.8%
Income Tax Expense136M77M106M254M190M
Net Income462M149M280M810M587M
Net Margin6.5%2.0%3.9%11.4%8.7%
EPS (Basic)3.751.212.256.564.82
EPS (Diluted)3.731.202.256.524.81
Weighted Avg Shares123.11M123.59M124.17M123.53M121.78M
Weighted Avg Shares (Diluted)123.91M124.18M124.8M124.29M122.13M

The Clorox Company

NYSE:CLX

Intrinsic Alpha fair value

Locked

Current Price

$108.39

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.